A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma.

Yan Song,Yue-Yue Zhang, Qin Yu, Tong Chen,Chao-Gang Wei,Rui Zhang,Wei Hu, Xu-Jun Qian,Zhi Zhu, Xue-Wu Zhang,Jun-Kang Shen

Frontiers in oncology（2023）

引用 0|浏览3

暂无评分

摘要

The nomogram constructed from LI-RADS features, quantitative contrast-enhanced MRI parameters and clinical indicators has high application value, can accurately predict GPC-3 expression in HCC and may help noninvasively identify potential patients for GPC-3 immunotherapy.

查看译文

关键词

Gd-EOB-DTPA,LI-RADS,glypican-3,hepatocellular carcinoma,immunotherapy,nomogram

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要